33 related articles for article (PubMed ID: 36646233)
1. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
Kim D; Manikat R; Shaikh A; Cholankeril G; Ahmed A
Eur J Clin Invest; 2024 Jan; 54(1):e14087. PubMed ID: 37638383
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis.
Liu Y; Zhong GC; Tan HY; Hao FB; Hu JJ
Sci Rep; 2019 Jul; 9(1):11124. PubMed ID: 31366982
[TBL] [Abstract][Full Text] [Related]
3. Association between biological aging and the risk of mortality in individuals with non-alcoholic fatty liver disease: A prospective cohort study.
Wang H; Liu Z; Fan H; Guo C; Zhang X; Li Y; Han X; Zhang T
Arch Gerontol Geriatr; 2024 May; 124():105477. PubMed ID: 38735225
[TBL] [Abstract][Full Text] [Related]
4. Population-Attributable Fractions of Nonalcoholic Fatty Liver Disease on All-Cause and Cause-Specific Mortality Risk: How Large is the Impact?
Qin L; Zhang K; Xie J
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):430. PubMed ID: 37127145
[No Abstract] [Full Text] [Related]
5. Time trends in liver-related mortality in people with and without diabetes: Results from a population based study.
Ciardullo S; Morabito G; Rea F; Savaré L; Perseghin G; Corrao G
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38506158
[TBL] [Abstract][Full Text] [Related]
6. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States.
Kim D; Wijarnpreecha K; Cholankeril G; Ahmed A
J Hepatol; 2024 Feb; 80(2):e79-e81. PubMed ID: 37717601
[No Abstract] [Full Text] [Related]
7. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action.
Younossi ZM; Henry L
Diabetes Spectr; 2024; 37(1):9-19. PubMed ID: 38385101
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study.
Adali G; Bilgic NM; Kalaman AE; Ozturk O; Ozdil K
Hepatol Forum; 2023; 4(3):129-134. PubMed ID: 37822311
[TBL] [Abstract][Full Text] [Related]
9. The growing burden of non-alcoholic fatty liver disease on mortality.
Cho JY; Sohn W
Clin Mol Hepatol; 2023 Apr; 29(2):374-376. PubMed ID: 36880212
[No Abstract] [Full Text] [Related]
10. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease.
Konyn P; Ahmed A; Kim D
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S43-S57. PubMed ID: 36417893
[TBL] [Abstract][Full Text] [Related]
11. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality.
de Avila L; Henry L; Paik JM; Ijaz N; Weinstein AA; Younossi ZM
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2588-2596.e3. PubMed ID: 36646233
[TBL] [Abstract][Full Text] [Related]
13. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
